GAFFX
Price
$86.38
Change
-$1.38 (-1.57%)
Updated
Jul 13 closing price
Net Assets
356.86B
JSGRX
Price
$30.13
Change
-$0.59 (-1.92%)
Updated
Jul 13 closing price
Net Assets
3.35B
Interact to see
Advertisement

GAFFX vs JSGRX

GAFFX vs JSGRX Comparison Chart in %
View a ticker or compare two or three
VS
GAFFX vs. JSGRX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a Buy and JSGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 357B vs. JSGRX (3.35B). GAFFX pays higher dividends than JSGRX: GAFFX (0.51) vs JSGRX (0.00). GAFFX was incepted earlier than JSGRX: GAFFX (9 years) vs JSGRX (11 years). JSGRX (1.11) is less costly to investors than GAFFX (0.29). JSGRX is a more actively managed with annual turnover of: 94.00 vs. GAFFX (32.00). JSGRX has a lower initial minimum investment than GAFFX: JSGRX (0) vs GAFFX (1000000). JSGRX annual gain was more profitable for investors over the last year : 5.82 vs. GAFFX (4.73). GAFFX return over 5 years is better than : 17.69 vs. JSGRX (13.74).
GAFFXJSGRXGAFFX / JSGRX
Total Expense Ratio0.291.1026%
Annual Report Gross Expense Ratio0.291.1126%
Fund Existence9 years11 years-
Gain YTD7.3314.846151%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets357B3.35B10,666%
Annual Yield % from dividends0.510.00-
Returns for 1 year4.735.8281%
Returns for 3 years40.9643.7594%
Returns for 5 years17.6913.74129%
Returns for 10 yearsN/A92.89-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EIIA25.260.13
+0.51%
Eagle Point Institutional Income Fund
COLA10.690.01
+0.09%
Columbus Acquisition Corp
USCB20.16N/A
N/A
USCB Financial Holdings
WAL80.49-0.20
-0.25%
Western Alliance Bancorporation
NTLA13.02-1.19
-8.41%
Intellia Therapeutics